A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of docetaxel and CNTO 328 when given
together as a treatment. The second goal of this study is to determine if a combination of
docetaxel and CNTO 328 has an effect on prostate cancer.